Tabletop Fire Pit Lawsuit Individuals who suffered severe burns, or families who lost a loved one in a tabletop fire pit explosion, may be eligible for financial compensation through a fire pit injury lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Pancreatitis Risks From Ozempic, Mounjaro Being Investigated by U.K. Regulators At least 10 pancreatitis deaths among users of Ozempic and other GLP-1 medications have occurred in the U.K. since the new class of weight loss and diabetes were first introduced. July 15, 2025 Irvin Jackson Add Your Comments Health officials in the United Kingdom want users of Ozempic, Mounjaro, Wegovy, Saxenda and similar medications to report any experiences with acute pancreatitis while, or after, using the popular diabetes and weight loss drugs. The U.K.’s Medicines and Healthcare products Regulatory Agency (MHRA) issued the request in a press release late last month, as part of a broader investigation into the potential side effects of GLP-1 receptor agonists, and an investigation into whether certain genetic factors may make some users more likely to develop pancreatitis. The most widely used GLP-1 medication is Novo Nordisk’s Ozempic (semaglutide), which was originally approved in 2017 to treat type 2 diabetes. However, its weight loss effects later led to the development of Wegovy, a version approved specifically for obesity. Eli Lilly’s competing drug, Mounjaro (tirzepatide), is also approved for diabetes, with a weight loss counterpart marketed as Zepbound. Other drugs in the GLP-1 class include Saxenda, Byetta, Victoza, Trulicity, Rybelsus and others. Since their introduction onto the market, Ozempic and other GLP-1s have become wildly popular, and there is growing evidence that the drugs may effectively treat a wide range of ailments. However, a growing number of individuals across the U.S. are now pursuing Ozempic lawsuits, Mounjaro lawsuits, Wegovy lawsuits and claims against the makers of other GLP-1 medications, indicating that all of the potential side effects and health risks were not adequately disclosed to users and the medical community. Find Out If You Have a Lawsuit Were you prescribed Ozempic, Wegovy or Mounjaro? Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects Learn More SEE IF YOU QUALIFY FOR COMPENSATION Find Out If You Have a Lawsuit Were you prescribed Ozempic, Wegovy or Mounjaro? Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects Learn More SEE IF YOU QUALIFY FOR COMPENSATION Most of the concerns over GLP-1 drug side effects have focused on the risks of gastrointestinal problems, such as gastroparesis, also known as stomach paralysis, intestinal blockages and ileus. Recent months have also seen new scientific evidence of Ozempic vision problems, which can lead to sudden and permanent vision loss. However, data released by the MHRA in early June revealed the agency was receiving a high number of pancreatitis cases that may be linked to GLP-1 use, some of them fatal. Pancreatitis has long been linked to the class, with the U.S. Food and Drug Administration (FDA) issuing a Byetta pancreatitis alert in 2008. As of the end of May 2025, the MHRA has linked at least five pancreatitis-related deaths to users of Mounjaro and Wegovy, and one death linked to Ozempic. In addition, the agency received at least 116 reported cases of acute and chronic pancreatitis by users of Saxenda, which resulted in at least one death. Another 101 incidents were linked to Byetta, resulting in three deaths. “GLP-1 medicines like Ozempic and Wegovy have been making headlines, but like all medicines there can be a risk of serious side effects. We believe there is real potential to minimise these with many adverse reactions having a genetic cause.” -Matt Brown, Chief Science Officer for Genomics England, MHRA press release The MHRA’s investigation, through its Yellow Card Biobank and a company known as Genomics England, will attempt to determine if there is a genetic cause as to why some users suffer severe pancreatitis problems while others do not. The Yellow Card system is the MHRA’s adverse drug event reporting program. GLP-1 Lawsuits in the U.S. There are nearly 2,000 GLP-1 lawsuits currently being pursued throughout the United States’ federal court system, focusing on gastrointestinal injuries, which have been centralized in the Eastern District of Pennsylvania under U.S. District Judge Karen Marston, as part of a GLP-1 lawsuit multidistrict litigation (MDL). To help test how juries may respond to certain evidence and testimony that will be central throughout thousands of individual claims, Judge Marston is presiding over coordinated discovery and pretrial proceedings to prepare a small group of cases for early trial dates. While the outcomes of these early test cases will not be binding on other claims, they will be closely watched and may help the parties negotiate GLP-1 settlements to resolve large numbers of lawsuits in the future. To stay up to date on this litigation, sign up to receive Ozempic lawsuit updates sent directly to your inbox. Find Out If You Qualify for Ozempic or Wegovy Compensation Tags: Byetta, Gastroparesis, GLP-1, Mounjaro, NAION, Ozempic, Pancreatitis, Saxenda, Stomach Paralysis, Wegovy, Zepbound Written By: Irvin Jackson Senior Legal Journalist & Contributing Editor Irvin Jackson is a senior investigative reporter at AboutLawsuits.com with more than 30 years of experience covering mass tort litigation, environmental policy, and consumer safety. He previously served as Associate Editor at Inside the EPA and contributes original reporting on product liability lawsuits, regulatory failures, and nationwide litigation trends. More Ozempic, Wegovy and Mounjaro Stories Mounjaro Stomach Paralysis Risks Higher Than Other Diabetes Drugs, Review Finds August 26, 2025 Gastric Emptying Study Will Be Required in Ozempic Gastroparesis Lawsuits: MDL Order August 20, 2025 Lawsuit Blames Ozempic, Mounjaro, Trulicity for Gastroparesis Diagnosis August 15, 2025 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermURLThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES DraftKings Micro-Betting Causes Addiction Risks in Vulnerable Users, Critics Warn (Posted: today) Lawsuits over gambling addictions are being brought against DraftKings, as regulators and health experts warn the platform’s push into micro-betting could heighten risks for vulnerable users. MORE ABOUT: SPORTS BETTING ADDICTION LAWSUITDraftKings Class Action Lawsuit Over $1,000 Bonus Bet Promo Dismissed by Federal Judge (08/01/2025)DraftKings ‘Risk-Free’ Bets, Other Promotions Instilled Gambling Addiction: Lawsuit (07/18/2025)FanDuel Class Action Lawsuit Alleges Fantasy Games Constitute Illegal Sports Gambling (07/08/2025) Talcum Powder Ovarian Cancer Settlement Negotiations Set To Kick Off Sept. 4 (Posted: yesterday) A federal judge has ordered parties involved in talcum powder ovarian cancer lawsuits to meet on September 4 to begin settlement negotiations. MORE ABOUT: TALCUM POWDER CANCER LAWSUITSWomen Will Have Voice in Any Settlement for Talcum Powder Lawsuits: Court (08/07/2025)Baby Powder Mesothelioma Lawsuit Ends in $42.6M Verdict for Massachusetts Family (08/01/2025)Talcum Powder Injury Lawyers Appointed To Negotiate Settlements With J&J (07/30/2025) Bard PowerPort Lawsuit Bellwether Trials Set To Begin March 2, 2026 (Posted: 2 days ago) A federal judge has released a schedule of the first six Bard PowerPort bellwether trials, which will be held throughout 2026. MORE ABOUT: BARD POWERPORT LAWSUITVancomycin May Increase Risk of Midline Catheter Complications: Study (08/13/2025)Chemo Port Infection Lawsuits Over Bard, AngioDynamics Catheters Allege Faulty Design Promotes Bacterial Growth (08/08/2025)Bard PowerPort Infection Lawsuit Chosen for First Bellwether Trial in Feb. 2026 (07/18/2025)
DraftKings Micro-Betting Causes Addiction Risks in Vulnerable Users, Critics Warn (Posted: today) Lawsuits over gambling addictions are being brought against DraftKings, as regulators and health experts warn the platform’s push into micro-betting could heighten risks for vulnerable users. MORE ABOUT: SPORTS BETTING ADDICTION LAWSUITDraftKings Class Action Lawsuit Over $1,000 Bonus Bet Promo Dismissed by Federal Judge (08/01/2025)DraftKings ‘Risk-Free’ Bets, Other Promotions Instilled Gambling Addiction: Lawsuit (07/18/2025)FanDuel Class Action Lawsuit Alleges Fantasy Games Constitute Illegal Sports Gambling (07/08/2025)
Talcum Powder Ovarian Cancer Settlement Negotiations Set To Kick Off Sept. 4 (Posted: yesterday) A federal judge has ordered parties involved in talcum powder ovarian cancer lawsuits to meet on September 4 to begin settlement negotiations. MORE ABOUT: TALCUM POWDER CANCER LAWSUITSWomen Will Have Voice in Any Settlement for Talcum Powder Lawsuits: Court (08/07/2025)Baby Powder Mesothelioma Lawsuit Ends in $42.6M Verdict for Massachusetts Family (08/01/2025)Talcum Powder Injury Lawyers Appointed To Negotiate Settlements With J&J (07/30/2025)
Bard PowerPort Lawsuit Bellwether Trials Set To Begin March 2, 2026 (Posted: 2 days ago) A federal judge has released a schedule of the first six Bard PowerPort bellwether trials, which will be held throughout 2026. MORE ABOUT: BARD POWERPORT LAWSUITVancomycin May Increase Risk of Midline Catheter Complications: Study (08/13/2025)Chemo Port Infection Lawsuits Over Bard, AngioDynamics Catheters Allege Faulty Design Promotes Bacterial Growth (08/08/2025)Bard PowerPort Infection Lawsuit Chosen for First Bellwether Trial in Feb. 2026 (07/18/2025)